血栓切除设备市场规模、份额和成长分析（按技术、类型、应用和地区）- 产业预测 2025-2032

2023 年血栓切除设备市场规模价值 20 亿美元，预计将从 2024 年的 21.4 亿美元成长到 2032 年的 36.5 亿美元，预测期间（2025-2032 年）的复合年增长率为 6.9%。

由于心血管疾病发病率上升、技术进步和人口老化，全球血栓切除设备市场预计将大幅成长。微创技术的创新，例如用于移除血栓的血栓摘取支架装置，显着改善了患者的治疗效果，同时减少了手术併发症和恢復时间。随着老年人口的增加，对有效血栓清除解决方案的需求也随之增加，因为老年人更容易患心血管疾病和血栓形成。这种人口结构的变化凸显了市场对先进治疗方案的需求。因此，美国血栓切除设备市场预计在未来预测期内以稳定的复合年增长率持续成长，满足老龄化人口的关键医疗需求。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

血栓切除设备市场规模（依技术及复合年增长率） (2025-2032)

• 市场概况
• 机械血栓切除术
• 血栓抽吸术
• 流变性血栓切除术

血栓切除设备市场规模（按类型和复合年增长率）（2025-2032）

• 市场概况
• 自动化设备
• 手动装置

血栓切除设备市场规模（按用途和复合年增长率） (2025-2032)

• 市场概况
• 可重复使用的设备
• 免洗设备

血栓切除设备市场规模（按应用划分）及复合年增长率（2025-2032）

• 市场概况
• 周围疾病
• 冠状动脉疾病
• 神经系统疾病

血栓切除设备市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Medtronic（Ireland）
• Abbott（United States）
• Boston Scientific（United States）
• Stryker（United States）
• Johnson & Johnson（United States）
• Penumbra（United States）
• Terumo（Japan）
• Koninklijke Philips（Netherlands）
• Becton, Dickinson and Company（BD）（United States）
• Merit Medical Systems（United States）
• Teleflex Incorporated（United States）
• AngioDynamics（United States）
• Edwards Lifesciences（United States）
• Cerenovus（United States）
• Vascular Solutions（United States）
• Balt Extrusion（United States）
• Acandis（Germany）

结论和建议

Thrombectomy Devices Market size was valued at USD 2.0 billion in 2023 and is poised to grow from USD 2.14 billion in 2024 to USD 3.65 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global market for thrombectomy devices is poised for substantial growth due to the rising prevalence of cardiovascular diseases, technological advancements, and an aging population. Innovations in minimally invasive technologies, like stent retriever devices for clot removal, have significantly enhanced patient outcomes while decreasing procedural complications and recovery times. As the geriatric population expands, so does the demand for effective thrombectomy solutions, given that older adults are more prone to cardiovascular issues and blood clot formation. This demographic shift underscores the necessity for advanced treatment options in the market. Consequently, the U.S. thrombectomy devices market is set for sustainable growth at a consistent CAGR in the upcoming forecast period, addressing critical healthcare needs in an aging society.

Top-down and bottom-up approaches were used to estimate and validate the size of the Thrombectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Thrombectomy Devices Market Segments Analysis

Global Thrombectomy Devices Market is segmented by Technology, Type, Utility, Application and region. Based on Technology, the market is segmented into Mechanical Thrombectomy, Aspiration Thrombectomy and Rheolytic Thrombectomy. Based on Type, the market is segmented into Automated Devices and Manual Devices. Based on Utility, the market is segmented into Reusable Devices and Disposable Devices. Based on Application, the market is segmented into Peripheral Diseases, Coronary Disease and Neural Diseases. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Thrombectomy Devices Market

The rising prevalence of cardiovascular diseases, such as strokes and heart attacks, is a major driving force behind the thrombectomy devices market. As more individuals age and adopt sedentary lifestyles, the incidence of these health issues continues to escalate. Thrombectomy devices are crucial for the rapid removal of blood clots, thereby restoring normal blood circulation and significantly improving patient outcomes. This increasing demand for effective treatment options highlights the importance of thrombectomy devices in modern medical practice, ultimately contributing to their growth within the healthcare industry. The combination of an aging population and lifestyle factors creates a pressing need for these innovative devices.

Restraints in the Thrombectomy Devices Market

The Thrombectomy Devices market faces certain restraints due to the inherent risks associated with thrombectomy procedures, much like other medical interventions. Complications such as vessel injury, bleeding, infection, or the risk of a clot becoming dislodged and leading to an embolism can arise. Such safety and efficacy concerns surrounding these devices may affect the choices made by both healthcare providers and patients, ultimately impacting the market's growth potential. These apprehensions regarding potential adverse outcomes could deter adoption rates, thereby posing challenges to the overall advancement and expansion of the thrombectomy devices market.

Market Trends of the Thrombectomy Devices Market

The Thrombectomy Devices market is experiencing a significant upward trend, driven by the increasing incidence of ischemic stroke, prompting heightened demand for sophisticated medical technologies. Key market players are intensifying their research and development initiatives to introduce innovative thrombectomy solutions, including advanced aspiration devices, clot retrievers, and specialized catheters. These devices are engineered with state-of-the-art technology that enhances tracking precision, facilitates seamless clot retrieval, and boasts user-friendly operations. As these advanced solutions become more accessible, healthcare professionals are better equipped to tackle the complexities of ischemic stroke treatment, ultimately leading to improved patient outcomes and a more resilient healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Thrombectomy Devices Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Mechanical Thrombectomy
• Aspiration Thrombectomy
• Rheolytic Thrombectomy

Global Thrombectomy Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Automated Devices
• Manual Devices

Global Thrombectomy Devices Market Size by Utility & CAGR (2025-2032)

• Market Overview
• Reusable Devices
• Disposable Devices

Global Thrombectomy Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Peripheral Diseases
• Coronary Disease
• Neural Diseases

Global Thrombectomy Devices Market Size & CAGR (2025-2032)

• North America (Technology, Type, Utility, Application)
  • US
  • Canada
• Europe (Technology, Type, Utility, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Type, Utility, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Type, Utility, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Type, Utility, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerenovus (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascular Solutions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt Extrusion (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations